NIH launches clinical trial of Epstein-Barr virus vaccine

Niaid.nih.gov

Klicken Sie hier, um Niaid.nih.gov zu abonnieren

Laden...

2 jahre vor

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

NIH launches clinical trial of Epstein-Barr virus vaccine 05/06/2022 10:00 AM EDT
EBV is the primary cause of infectious mononucleosis and is associated with certain cancers and autoimmune diseases.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Teilen auf

Laden...

Weitere Newsletter von Niaid.nih.gov

Spotlight on Herbs and Other Botanicals Niaid.nih.gov
Vor 16 Stunden
Find a plan for 2025! There is still time to enroll Niaid.nih.gov
Vor 20 Stunden
HRSA Supports Rural Health Care Niaid.nih.gov
Letzten Freitag um 18:07

Weitere Newsletter von Niaid.nih.gov

Laden...

NIH launches clinical trial of Epstein-Barr virus vaccine

Teilen auf

Weitere Newsletter von Niaid.nih.gov

Verwandte Newsletter